AlphaCrest Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $3.03M | Buy |
|
|||||
|
2022
Q2 | $2.7M | Buy |
|
|||||
|
2022
Q1 | $1.63M | Sell |
|
|||||
|
2021
Q4 | $2.71M | Buy |
|
|||||
|
2021
Q3 | $1.33M | Sell |
|
|||||
|
2021
Q2 | $2.41M | Buy |
|
|||||
|
2021
Q1 | $1.12M | Buy |
|
|||||
|
2020
Q4 | $1.06M | Buy |
|
|||||
|
2020
Q3 | $874K | Buy |
|
|||||
|
2020
Q2 | $230K | Sell |
|
|||||
|
2020
Q1 | $1.1M | Sell |
|
|||||
|
2019
Q4 | $1.41M | Sell |
|
|||||
|
2019
Q3 | $1.21M | Buy |
|
|||||
|
2019
Q2 | $1.12M | Buy |
|
|||||
|
2019
Q1 | $454K | Buy |
|